Meet our first patient: Carolyn Boone.
Carolyn Boone is a mullerian sarcoma patient. She was the first patient enrolled in an ARIAD clinical trial of ridaforolimus (formerly known as deforolimus).
ARIAD exists for people like Carolyn. Our vision, our passion, our drive is to discover, develop and commercialize drugs that truly make a difference for people with cancer.